Related Experiment Video
Updated: Jul 29, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
First thousand rectal cancer cases--local recurrence and survival
Z Krivokapic1, G Barisic, V Markovic
1Institute for Digestive Diseases, First Surgical Clinic, Belgrade.
Sphincter-saving procedures (SSP) for rectal cancer show comparable local recurrence and survival rates to abdominoperineal resections (APR). Transection of the mesorectum is safe for tumors located more than 8 cm from the anal verge, suggesting SSP should be encouraged.
Area of Science:
- Colorectal Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Rectal carcinoma necessitates surgical intervention, with various procedures including sphincter-saving procedures (SSP) and abdominoperineal resections (APR).
- The choice of surgical technique impacts patient outcomes, including local recurrence rates and long-term survival.
Purpose of the Study:
- To compare the outcomes of sphincter-saving procedures (SSP) versus abdominoperineal resections (APR) in patients with rectal carcinoma.
- To evaluate the efficacy of different mesorectal dissection techniques within SSP.
Main Methods:
- Retrospective analysis of 1095 patients who underwent curative SSP or APR for rectal carcinoma between 1990-2002.
- Categorization of SSP into high colorectal anastomosis, low anastomosis, and intersphincteric coloanal anastomosis.
- Comparison of local recurrence rates, mortality, and five-year survival between SSP and APR groups, including subgroups based on mesorectal transection technique (TME vs. transection).
Main Results:
- SSP was performed in 767 patients and APR in 328 patients. Local recurrence rates were 6.9% for SSP and 8.5% for APR. Five-year survival was 0.72 for SSP and 0.64 for APR (p < .001).
- Within the SSP group, local recurrence was 7.6% with total mesorectal excision (TME) and 5.6% with mesorectal transection. Survival was 0.75 with TME and 0.72 with transection (p < .05).
- Mortality rates were 20.1% for SSP and 24.4% for APR.
Conclusions:
- Sphincter-saving procedures (SSP) offer comparable oncological outcomes to abdominoperineal resections (APR) for rectal cancer and should be encouraged when feasible.
- Mesorectal transection is a safe and effective technique for tumors located more than 8 cm from the anal verge within the SSP approach.
- Optimizing preoperative staging and considering neoadjuvant radiotherapy may further improve outcomes in rectal cancer surgery.
More Related Videos
08:26Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024